Literature DB >> 22019164

Amelioration of renal ischemia-reperfusion injury with a novel protective cocktail.

Thambi Dorai1, Andrew I Fishman, Cheng Ding, Ines Batinic-Haberle, David S Goldfarb, Michael Grasso.   

Abstract

PURPOSE: Extended warm ischemia during partial nephrectomy can lead to considerable renal injury. Using a rat model of renal ischemia we examined the ability of a unique renoprotective cocktail to ameliorate warm ischemia-reperfusion injury.
MATERIALS AND METHODS: A warm renal ischemia model was developed using 60 Sprague-Dawley® rats. The left renal artery was clamped for 40 minutes, followed by 48 hours of reperfusion. A renoprotective cocktail of a mixture of specific growth factors, mitochondria protecting biochemicals and Manganese-Porphyrin (MnTnHex-2-PyP(5+)) was given intramuscularly at -24, 0 and 24 hours after surgery. At 48 hours the 2 kidneys were harvested and examined with hematoxylin and eosin, and periodic acid-Schiff stains. Protein and gene expression were also analyzed to determine ischemia markers and the antioxidant response.
RESULTS: Compared to ischemic controls, kidneys treated with the renoprotective cocktail showed significant reversal of morphological changes and a significant decrease in the specific ischemic markers lipocalin-2, mucin-1 and galectin-3. Quantitative reverse transcriptase-polymerase chain reaction revealed up-regulation of several antioxidant genes in treated animals.
CONCLUSIONS: According to histopathological and several molecular measures our unique renoprotective cocktail mitigated ischemia-reperfusion injury. Copyright Â
© 2011 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22019164     DOI: 10.1016/j.juro.2011.08.010

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  20 in total

1.  Mn porphyrin-based SOD mimic, MnTnHex-2-PyP(5+), and non-SOD mimic, MnTBAP(3-), suppressed rat spinal cord ischemia/reperfusion injury via NF-κB pathways.

Authors:  T Celic; J Španjol; M Bobinac; A Tovmasyan; I Vukelic; J S Reboucas; I Batinic-Haberle; D Bobinac
Journal:  Free Radic Res       Date:  2014-10-10

Review 2.  Mn Porphyrin-Based Redox-Active Drugs: Differential Effects as Cancer Therapeutics and Protectors of Normal Tissue Against Oxidative Injury.

Authors:  Ines Batinic-Haberle; Artak Tovmasyan; Ivan Spasojevic
Journal:  Antioxid Redox Signal       Date:  2018-08-28       Impact factor: 8.401

Review 3.  Manganese superoxide dismutase, MnSOD and its mimics.

Authors:  Sumitra Miriyala; Ivan Spasojevic; Artak Tovmasyan; Daniela Salvemini; Zeljko Vujaskovic; Daret St Clair; Ines Batinic-Haberle
Journal:  Biochim Biophys Acta       Date:  2011-12-09

4.  Cytotoxic effects of Mn(III) N-alkylpyridylporphyrins in the presence of cellular reductant, ascorbate.

Authors:  Xiaodong Ye; Diane Fels; Artak Tovmasyan; Katherine M Aird; Casey Dedeugd; Jennifer L Allensworth; Ivan Kos; Won Park; Ivan Spasojevic; Gayathri R Devi; Mark W Dewhirst; Kam W Leong; Ines Batinic-Haberle
Journal:  Free Radic Res       Date:  2011-09-27

5.  Mn porphyrins as a novel treatment targeting sickle cell NOXs to reverse and prevent acute vaso-occlusion in vivo.

Authors:  Madhan Thamilarasan; Rodolfo Estupinan; Ines Batinic-Haberle; Rahima Zennadi
Journal:  Blood Adv       Date:  2020-06-09

6.  Protective effect of Urtica dioica L. on renal ischemia/reperfusion injury in rat.

Authors:  Mustafa Burak Sayhan; Mehmet Kanter; Serhat Oguz; Mustafa Erboga
Journal:  J Mol Histol       Date:  2012-07-04       Impact factor: 2.611

7.  Radiation-Mediated Tumor Growth Inhibition Is Significantly Enhanced with Redox-Active Compounds That Cycle with Ascorbate.

Authors:  Artak Tovmasyan; Jacqueline C Bueno-Janice; Melba C Jaramillo; Romulo S Sampaio; Julio S Reboucas; Natalia Kyui; Ludmil Benov; Brian Deng; Ting-Ting Huang; Margaret E Tome; Ivan Spasojevic; Ines Batinic-Haberle
Journal:  Antioxid Redox Signal       Date:  2018-03-27       Impact factor: 8.401

Review 8.  SOD therapeutics: latest insights into their structure-activity relationships and impact on the cellular redox-based signaling pathways.

Authors:  Ines Batinic-Haberle; Artak Tovmasyan; Emily R H Roberts; Zeljko Vujaskovic; Kam W Leong; Ivan Spasojevic
Journal:  Antioxid Redox Signal       Date:  2013-10-01       Impact factor: 8.401

9.  Manganoporphyrins increase ascorbate-induced cytotoxicity by enhancing H2O2 generation.

Authors:  Malvika Rawal; Samuel R Schroeder; Brett A Wagner; Cameron M Cushing; Jessemae L Welsh; Anna M Button; Juan Du; Zita A Sibenaller; Garry R Buettner; Joseph J Cullen
Journal:  Cancer Res       Date:  2013-06-13       Impact factor: 12.701

10.  Novel Manganese-Porphyrin Superoxide Dismutase-Mimetic Widens the Therapeutic Margin in a Preclinical Head and Neck Cancer Model.

Authors:  Kathleen A Ashcraft; Mary-Keara Boss; Artak Tovmasyan; Kingshuk Roy Choudhury; Andrew N Fontanella; Kenneth H Young; Gregory M Palmer; Samuel R Birer; Chelsea D Landon; Won Park; Shiva K Das; Tin Weitner; Huaxin Sheng; David S Warner; David M Brizel; Ivan Spasojevic; Ines Batinic-Haberle; Mark W Dewhirst
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-07-29       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.